NCT Number: NCT07661017
There are two components to the study: a patient and a clinician study. The clinician study will include one-hour semi-structured interviews with oncology specialists to identify facilitators and barriers to integrating digital diet interventions into the clinical workflow, and to understand their needs and preferences for digital diet interventions. The patient study aims to investigate initial feasibility, efficacy and acceptability of the GutCheck app and intervention. It will last 9 weeks and involves 2 study visits and 2 active phases with a transition week and optional transition visit between phases. During active phases, participants will be asked to use the GutCheck app every day. Prior to the first active phase, participants will go through informed consent and app training. The first active phase will last two weeks and will focus on tracking participants' diet, gastrointestinal (GI) symptoms, and stress. The data collected during the first active phase will be used to identify any potential trigger foods that may contribute to GI symptoms, but only if the participant reports experiencing GI symptoms. Between active phases, participants will have one Transition Week, where results from the first phase are given to the participants with the option to attend a Transition Week Visit. The second active phase will last four weeks and will involve the message intervention. A single-blind, micro-randomized trial design will be used to repeatedly randomize participants to different intervention combinations, determining both the timing and frequency of intervention message delivery throughout the day. Lastly, there will be an exit visit and interview within a week from the intervention to collect post-intervention measures and ask about the participant's experience with the GutCheck app.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion
Survivors of GI cancer are eligible if they are:
Inclusion criteria
for oncology specialists (oncologists, advanced practice providers, nurses, dietitians, and patient navigators) include:
Exclusion
Oncology specialists' exclusion criteria include:
Participants who were selected to collect their stool samples will be mailed their second kit before the last week (week 8) of intervention. Participants will collect their stool sample during week 8 and mail them to be processed prior to the Exit Interview Visit.
Participants will be asked to log their food and beverages, stress, and gastrointestinal symptoms daily. They will also track physical activity.
Time frame: 1 year
Average count of days where the participant tracked at least two episodes a day.
Time frame: 1 year
Average count of days of GI symptom and stress tracking combination (i.e., once a day for two weeks for both).
Contact information is provided by the study sponsor or research team.
Masonic Cancer Center, University of Minnesota
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07423897
Gastrointestinal, Gut Health
Los Angeles, California, United States
View Trial DetailsNCT07720362
Gastrointestinal, Microbiota
Richmond, Virginia, United States
View Trial DetailsNCT07717359
ADHD, Attention Deficit Disorder with Hyperactivity
View Trial DetailsNCT07197749
Gastrointestinal, Graft vs Host Disease
View Trial Details